Alvario-Martn C, Sarrin-Prez MG. Prevention and treatment of oral mucositis in patients receiving chemotherapy. J Clin Exp Dent. 2014;6(1):e74-80.

 

doi:10.4317/jced.51313

http://dx.doi.org/doi:10.4317/jced.51313

 

References

1. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck. 2004;26:77-84.

http://dx.doi.org/10.1002/hed.10326

PMid:14724910                                                                   

                                                                     

2. Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, de Vries EG. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res. 2006;85:690-700.

http://dx.doi.org/10.1177/154405910608500802

PMid:16861284                                                                   

                                                                     

3. Rodriguez-Caballero A, Torres-Lagares D, Robles-Garca M, Pachon-Iba-ez J, Gonzalez-Padilla D, Gutierrez-Perez JL. Cancer treatment-induced oral mucositis: a critical review. Int J Oral Maxillofac Surg. 2012;41:225-38.

http://dx.doi.org/10.1016/j.ijom.2011.10.011

PMid:22071451                                                                   

                                                                     

4. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:1995-2025.

http://dx.doi.org/10.1002/cncr.20162

PMid:15108222                                                                   

                                                                     

5. Hernndez-Fernndez A, O-ate-Snchez RE, Cabrerizo-Merino MC, de Arriba-de la-Fuente F, Heras-Fernando I, Vicente-Garca V. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Med Oral Patol Oral Cir Bucal. 2012;17:e94-e101.

http://dx.doi.org/10.4317/medoral.16997

PMid:22157660 PMCid:PMC3448185                                                      

                                                                     

6. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004;100:2026-46.

http://dx.doi.org/10.1002/cncr.20163

PMid:15108223                                                                   

                                                                     

7. Bjordal JM, Bensadoun RJ, Tunr J, Frigo L, Gjerde K, Lopes-Martins RA. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer. 2011;19:1069-77.

http://dx.doi.org/10.1007/s00520-011-1202-0

PMid:21660670                                                                   

                                                                     

8. Sabater Recolons Mdel M, Lpez Lpez J, Rodrguez de Rivera Campillo ME, Chimenos Kstner E, Conde Vidal JM. Buccodental health and oral mucositis. Clinical study in patients with hematological diseases. Med Oral Patol Oral Cir Bucal. 2006;11:E497-502.

PMid:17072254                                                                   

                                                                     

9. Lpez-Casta-o F, O-ate-Snchez RE, Roldn-Chicano R, Cabrerizo-Merino MC. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review. Med Oral Patol Oral Cir Bucal. 2005;10:412-21.      PMID: 16264377                            

                                                                     

10. Harris DJ, Eilers J, Harriman A, Cashavelly BJ, Maxwell C. Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs. 2008;12:141-52.

http://dx.doi.org/10.1188/08.CJON.141-152

PMid:18258584                                                                   

                                                                     

11. NHMRC. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra: NHMRC. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp30.pdf                                                                                                              

                                                                     

12. McGuire DB, Correa ME, Johnson J, Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer. 2006;14:541-7.

http://dx.doi.org/10.1007/s00520-006-0051-8

PMid:16775649                                                                   

                                                                     

13. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109:820-31.

http://dx.doi.org/10.1002/cncr.22484

PMid:17236223                                                                   

                                                                     

14. Nashwan AJ. Use of chlorhexidine mouthwash in children receiving chemotherapy: a review of literature. J Pediatr Oncol Nurs. 2011;28:295-9.

http://dx.doi.org/10.1177/1043454211408103

PMid:21821553                                                                   

                                                                     

15. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, et al. For The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer. 2012.

PMid:23052919                                                                   

                                                                     

16. Buentzel J, Micke O, Adamietz IA, Monnier A, Glatzel M, de Vries A. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys. 2006;64:684–91.

http://dx.doi.org/10.1016/j.ijrobp.2005.08.005

PMid:16243440                                                                   

                                                                     

17. Nottage M, McLachlan SA, Brittain MA, Oza A, Hedley D, Feld R, et al. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial. Support Care Cancer. 2003;11:41-7.

PMid:12527953                                                                   

                                                                     

18. Pytlik R, Benes P, Patorkova M, et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant. 2002;30:953-61.

http://dx.doi.org/10.1038/sj.bmt.1703759

PMid:12476290                                                                   

                                                                     

19. Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, et al. Double-blinded, placebocontrolled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;65:1330-7.

http://dx.doi.org/10.1016/j.ijrobp.2006.03.042

PMid:16765532                                                                   

                                                                     

20. Sornsuvit C, Komindr S, Chuncharunee S, Wanikiat P, Archararit N, Santanirand P. Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy induced side-effects in acute myeloid leukaemia patients. J Int Med Res. 2008;36:1383-91.

http://dx.doi.org/10.1177/147323000803600628

PMid:19094450                                                                   

                                                                     

21. Panahi Y, Ala S, Saeedi M, Okhovatian A, Bazzaz N, Naghizadeh MM. Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis. Eur J Cancer Care. 2010;19:308-12.

http://dx.doi.org/10.1111/j.1365-2354.2008.01042.x

PMid:19659665                                                                   

                                                                     

22. Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, et al. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer. 2012.                                                                  

                                                                     

23. Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer. 2008;112:1600–6.

http://dx.doi.org/10.1002/cncr.23328

PMid:18300265                                                                   

                                                                     

24. Papadeas E, Naxakis S, Riga M, Kalofonos C. Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study. Eur J Oncol Nurs. 2007;11:60-5.

http://dx.doi.org/10.1016/j.ejon.2006.05.002

PMid:16829196                                                                   

                                                                     

25. Nikoletti S, Hyde S, Shaw T, Myers H, Kristjanson LJ. Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. J Clin Nurs. 2005;14:750-3.

http://dx.doi.org/10.1111/j.1365-2702.2005.01156.x

PMid:15946283                                                                   

                                                                     

26. Gori E, Arpinati M, Bonifazi F, Errico A, Mega A, Alberani F, et al. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplant. 2007;39:347-52.

http://dx.doi.org/10.1038/sj.bmt.1705590

PMid:17277790                                                                   

                                                                     

27. Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L, et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2006;37:1031-5.

http://dx.doi.org/10.1038/sj.bmt.1705384

PMid:16633359                                                                   

                                                                     

28. Svanberg A, Birgegard G, Ohrn K. Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial. Support Care Cancer. 2007;15:1155-61.

http://dx.doi.org/10.1007/s00520-007-0245-8

PMid:17393189                                                                   

                                                                     

29. Raber-Durlacher JE, von Bltzingslwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, et al. For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2012.                                                                     

                                                                     

30. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590-8.

http://dx.doi.org/10.1056/NEJMoa040125

PMid:15602019                                                                   

                                                                     

31. Blazar BR, Weisdorf DJ, Defor T, Goldman A, Braun T, Silver S, et al. Phase ½ randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood. 2006;108:3216-22.

http://dx.doi.org/10.1182/blood-2006-04-017780

PMid:16835378 PMCid:PMC1895527                                                      

                                                                     

32. Brizel DM,Murphy BA, Rosenthal DI, Pandya KJ, Gluck S, Brizel HE, et al.Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. J Clin Oncol. 2008;26:2489-96.

http://dx.doi.org/10.1200/JCO.2007.13.7349

PMid:18487568                                                                   

                                                                     

33. Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol. 2011;29:2815-20.

http://dx.doi.org/10.1200/JCO.2010.32.4103

PMid:21670447                                                                   

                                                                     

34. Le QT, Kim HE, Schneider CJ, Murakozy G, Skladowski K, Reinisch S, et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol. 2011;29:2808-14.

http://dx.doi.org/10.1200/JCO.2010.32.4095

PMid:21670453                                                                   

                                                                     

35. Meropol NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J Clin Oncol. 2003;21:1452-8.

http://dx.doi.org/10.1200/JCO.2003.10.079

PMid:12697866                                                                   

                                                                     

36. Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, et al.Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol. 2006;24:5194-200.

http://dx.doi.org/10.1200/JCO.2005.04.1152

PMid:17075109                                                                   

                                                                     

37. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, et al. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomised trial. Ann Intern Med. 2010;153:358-67.

http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00003

PMid:20855800                                                                   

                                                                     

38. Dazzi C, Cariello A, Giovanis P, Monti M, Vertogen B, Leoni M, et al. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Ann Oncol. 2003;14:559-63.

http://dx.doi.org/10.1093/annonc/mdg177

PMid:12649101                                                                   

                                                                     

39. Valcarcel D, Sanz MA Jr, Sureda A, Sala M, Munoz L, Subira M, et al. Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study. Bone Marrow Transplant. 2002;29:783-7.

http://dx.doi.org/10.1038/sj.bmt.1703543

PMid:12040477                                                                   

                                                                     

40. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, et al.; For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2012.

PMid:23001179                                                                   

                                                                     

41. Schubert MM, Eduardo FP, Guthrie KA et al. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer. 2007;15:1145-54.

http://dx.doi.org/10.1007/s00520-007-0238-7

PMid:17393191                                                                   

                                                                     

42. Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adao CA, Pinheiro CT, Mayhe R, et al. Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood. 2007;109:2250-5.

http://dx.doi.org/10.1182/blood-2006-07-035022

PMid:17053058                                                                   

                                                                     

43. Cruz LB, Ribeiro AS, Rech A, Rosa LG, Castro CG Jr, Brunetto AL, et al. Influence of low-energy laser in the prevention of oral mucositis in children with cncer receiving chemotherapy. Pediatr Blood Cancer. 2007;48(4):435-40.

http://dx.doi.org/10.1002/pbc.20943

PMid:16862549                                                                   

                                                                      

44. Gouvea de Lima A, Villar RC, De Castro G Jr, et al. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys. 2012;82:270-5.

http://dx.doi.org/10.1016/j.ijrobp.2010.10.012

PMid:21163585                                                                   

                                                                     

45. Genot-Klastersky MT, Klastersky J, Awada F, Awada A, Crombez P, Martinez MD, et al. The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Supportive Care Cancer. 2008;16:1381-7.

http://dx.doi.org/10.1007/s00520-008-0439-8

PMid:18458964                                                                   

                                                                     

46. Kuhn A, Porto FA, Miraglia P, Brunetto AL. Low level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. J Pediatr Hematol Oncol. 2009; 31:33-7.

http://dx.doi.org/10.1097/MPH.0b013e318192cb8e

PMid:19125084                                                                   

                                                                     

47. Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2011;13:CD000978.                                                                 

PMID: 21491378

                                                                     

48. Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2010;4:CD001973.                                                               

PMID: 21154347